Economy

Session Recap: Viewing Unusual Volume for Ascendis Pharma A/S (NASDAQ:ASND)

Wedbush reissued an outperform rating and issued a $10.71 target price (down previously from $65.00) on shares of Ascendis Pharma A/S in a report on Friday. EcoR1 Capital LLC now owns 1,482,600 shares of the biotechnology company's stock valued at $41,157,000 after purchasing an additional 456,900 shares in the last quarter. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. About 2.72M shares traded or 2126.90% up from the average.

XAutoplay: On | OffIn after-hours trading on the stock market today, Versartis dove 84% after closing down 1.1% at 21.60. The business's quarterly revenue was down 61.4% compared to the same quarter previous year. The Massachusetts-based Monarch Partners Asset Management Llc has invested 0.31% in the stock.

A number of research firms have recently issued reports on ASND.

Ascendis Pharma A/S (NASDAQ:ASND)'s market cap, the total dollar value of all of their outstanding shares, is 1100.82m.

Current levels places Ascendis Pharma A/S (NASDAQ:ASND)'s stock about 14.86% from the 50-day high and 30.19% away from the 50-day low.

Among 5 analysts covering Ascendis Pharma (NASDAQ:ASND), 4 have Buy rating, 0 Sell and 1 Hold. Wedbush maintained it with "Outperform" rating and $34 target in Friday, March 24 report. Finally, ValuEngine raised shares of Ascendis Pharma A/S from a "sell" rating to a "hold" rating in a research note on Saturday, May 27th. The stock has "Buy" rating by Wedbush on Monday, September 11. Ascendis Pharma A/S now has an average rating of "Hold" and an average target price of $30.00. Wedbush maintained Ascendis Pharma A S (NASDAQ:ASND) rating on Friday, September 22.

About 44,382 shares traded. Wells Fargo & Company restated a "buy" rating and issued a $51.00 price target on shares of Ascendis Pharma A/S in a research report on Friday. The biotechnology company reported ($1.04) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.80) by ($0.24). Analysts forecast earnings per share of $-0.84, down exactly $0.04 or 5.00 % from 2014's $-0.8 EPS.

Looking ahead, Ascendis' phase 3 heiGHt trial for TC-hGH treatment of pediatric growth hormone deficiency is on track to finish enrollment in the fourth quarter of this year.

According to TipRanks.com, which ranks over 7,500 financial analysts and bloggers to gauge the performance of their past recommendations, Jim Birchenough and Liana Moussatos have a yearly average return of 26.9% and 8.6% respectively. Ascendis Pharma A S (NASDAQ:ASND) has risen 96.01% since September 23, 2016 and is uptrending.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Equities Focus and is the property of of Equities Focus.

Traders are a little more bearish on Ascendis Pharma A/S - American if you take note of the increase in short interest. The Company is involved in applying its TransCon technology to develop sustained release prodrug therapies with several product candidates in clinical and preclinical development.



Like this

loading...
loading...

Latest


24 September 2017
China committed to denuclearization of Korean Peninsula: FM
He singled out North Korea's textiles, fishing, information technology and manufacturing industries as the principal targets. Lu was speaking after United States President Donald Trump signed a new order to boost sanctions against Pyongyang.

24 September 2017
Parker retains WBO world heavyweight title
Parker, meanwhile, attempted to walk Fury down before landing with his powerful right hand, but he often missed wildly. Two judges scored the bout comfortably for Parker, 118-110, while the third had the fight even at 114 apiece.

24 September 2017
Trump Slaps New Sanctions on North Korea
According to United Nations customs data, Beijing sent 6,000 barrels a day of oil products to North Korea in 2016. All six of North Korea's nuclear tests thus far, dating to 2006, have been conducted in underground tunnels.

24 September 2017
Strong afterschock hits Mexico City
Oaxaca state government reported homes collapsed and a woman died when a wall of her home fell on her in Asuncion Ixtaltepec. He said he's left helpless from a distance as his community tries to search for loved ones and also tries to rebuild.

24 September 2017
Ander Herrera labels Manchester City as title favourites due to summer spending
The Blues' last league outing saw David Luiz become the fourth man sent off for them this season, including the Community Shield. We won three titles last season and City didn't win anything. "But I don't see them as a team with a discipline problem".

24 September 2017
SC escapes Louisiana Tech with late field goal
Redshirt freshman Parker White connected on a 31-yard field goal with five seconds left to lift the Gamecocks. Louisiana Tech: The Bulldogs host South Alabama on Saturday in their final non-conference game of the year.

24 September 2017
Arsenal forward Welbeck out for at least one month
One name which will be missing, however, is Danny Welbeck , after the England striker suffered yet another injury setback. The England worldwide suffered the injury in the last quarter of the Gunners' goalless draw with Chelsea on Sunday.

24 September 2017
OR vs. Arizona State 9/23/17
And considering that the Sun Devils are averaging 20 ½ points at home this season, the under line seems like the only way to go. OR football unveiled the kits on their Twitter account earlier today, and like most OR uniforms, they do not disappoint.

24 September 2017
Guggenheim Capital LLC Acquires 14427 Shares of Ameriprise Financial Services, Inc. (AMP)
Finally, Airain ltd purchased a new stake in shares of Ameriprise Financial Services during the 2nd quarter valued at $1,184,000. Following the completion of the transaction, the vice president now owns 10,956 shares in the company, valued at $1,590,263.40.

24 September 2017
North Carolina State upsets Florida State
Florida State fell to 0-2 on the season in spite of entering the year ranked No. 3 by the Associated Press in the top-25 poll. He's completing about 66 percent of his passes for 72 yards and a touchdown through the halfway mark of the second quarter.